Clinical Trial Update: A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy [Phase 3]

View source ↗

Summary

Phase 3 trial of AXS-12 (Reboxetine) in narcolepsy with cataplexy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataplexy
• Narcolepsy

Drugs mentioned

• AXS-12 (Reboxetine)

Snippet

Sponsor: Axsome Therapeutics, Inc. | Conditions: Narcolepsy, Cataplexy | Phase 3 | Status: COMPLETED